Screener
Praxis Precision Medicines, Inc. PRAX Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net loss | $(176,281) | $(140,423) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation expense | 72 | 93 |
| Stock-based compensation expense | 28,421 | 16,556 |
| Non-cash operating lease expense | 516 | 506 |
| Amortization of premiums and discounts on marketable securities, net | (1,344) | (2,216) |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | (2,188) | 6,917 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s stock-based comp?
- Praxis Precision Medicines, Inc. (PRAX) reported stock-based comp of $11.31M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s stock-based comp changed year-over-year?
- Praxis Precision Medicines, Inc.'s stock-based comp increased by 45.5% year-over-year, from $7.77M to $11.31M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s stock-based comp has grown at a 10.6% compound annual growth rate (CAGR), from $22.69M to $33.94M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Praxis Precision Medicines, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude